OGN vs VIRT · P/E 3.4, rev $6.40B vs P/E 13, rev $2.88B
Organon & Co (OGN) versus Virtu Financial, Inc. (VIRT) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Not investment advice. Open the OGN and VIRT stock pages for the full models.
Not investment advice.